Inflammation has a role in urethane‑induced lung cancer in C57BL/6J mice

  • Authors:
    • Cai Xu
    • Lingyu Zhou
    • Lei Lu
    • Ting Chen
    • Siyu Wei
    • Xiaojing Lin
    • Xuemei Lian
  • View Affiliations

  • Published online on: August 19, 2016     https://doi.org/10.3892/mmr.2016.5661
  • Pages: 3323-3328
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lung cancer is a common and highly frequent cause of cancer‑associated mortality worldwide. Several studies have indicated that chronic inflammation is associated with an increased risk of several types of human cancer. The lung is vulnerable to various chemical and biological insults, and persistent exposure to these factors may result in the release of several inflammatory cytokines from inflammatory cells, thus leading to chronic inflammation and a risk of lung cancer. Due to the extensive application of C57BL/6J mice in lipid metabolism‑related research, it appears important to establish a lung cancer model based on C57BL/6J mice. Therefore, the present study designed an experimental model, in which C57BL/6J mice received several injections of urethane. The study aimed to explore whether inflammation has a role in this model of lung cancer. The results demonstrated that 10 weekly intraperitoneal injections of urethane induced a 100% lung tumor incidence, and urethane‑treated mice possessed higher numbers of immune cells. In addition, the expression levels of cytokines and chemokines in bronchoalveolar lavage fluid were significantly different between the two groups. Activation of the transcription factor nuclear factor‑κB was increased in the lung tissues of urethane‑treated mice, and its expression was upregulated in a time‑dependent manner. These results suggested that the accumulation of lung inflammation may be associated with the occurrence of lung cancer in C57BL/6J mice.

Introduction

Lung cancer is a common and highly frequent cause of cancer-associated mortality worldwide (1,2). In addition, the occurrence of lung cancer between mice and humans is similar, particularly adenocarcinoma (3). The incidence and outcome of lung injury and inflammation are associated with the nature of the precipitating disease, and individual susceptibility (4). Genetic susceptibility has been reported to have an important role in the induction and development of lung injury in humans (5) and animals (6), and various mouse strains display a variation in susceptibility to lung tumor induction. In current lung cancer research, a urethane model of lung cancer has been widely used, particularly in BALB/c mice (7). Previous studies have demonstrated that C57BL/6J mice are not very sensitive to urethane-induced lung cancer (8,9). However, with the extensive application of C57BL/6J mice in lipid metabolism-related research, it appears important to establish a lung cancer model based on C57BL/6J mice.

It has previously been reported that chronic inflammation is associated with an increased risk of several types of human cancer (10). The lung is vulnerable to various chemical and biological insults, and persistent exposure to these factors may induce the release of several inflammatory cytokines from inflammatory cells, consequently leading to chronic inflammation and an increased risk of lung cancer (11,12). Inflammatory cells in the tumor microenvironment may release cytokines to directly stimulate oncogenic signaling in cancer cells, including nuclear factor (NF)-κB, thus promoting cancer survival and proliferation (12). The present study designed an experimental model, in which C57BL/6J mice received numerous injections of urethane. The present study aimed to determine whether inflammation has a role in this lung cancer model. The results demonstrated that accumulation of lung inflammation was associated with the occurrence of lung cancer in C57BL/6J mice.

Materials and methods

Animals and experimental design

A total of 40 male C57BL/6J mice (age, 6–8 weeks, weight, 12.40–14.79 g; 20 per group) were obtained from the animal facility of Chongqing Medical University (Chongqing, China) and maintained in a controlled environment (12-h light/dark cycle, ad libitum access to food and water) at the laboratory animal facility of Chongqing Medical University (Chongqing, China). All methods used in the present study were approved by the Animal Care and Use Committee at Chongqing Medical University. After 3 weeks of adaptive feeding, the mice were randomly divided into two groups: The urethane group, which received intraperitoneal (i.p) injections of urethane (1 mg/g body weight; U2500; Sigma-Aldrich; Merck Millipore, Darmstadt, Germany) freshly dissolved in 0.9% saline; or the control group, which received an equal volume of saline. The mice were treated with urethane or saline once a week for 10 consecutive weeks. At various time points, mice were sacrificed using pentobarbital sodium (0.2 mg/g), blood was collected by cardiac puncture. Simultaneously, bronchoalveolar lavage fluid (BALF) and lung tissues were carefully collected. Tumorigenesis assessments were conducted after a 15-week latency period, as described previously (13). Mice were sacrificed at various time periods: Experimental week 13 (following continuous i.p injections of urethane or saline for 10 weeks) or experimental week 28 (final point) for further studies (Fig. 1A).

Histology and immunohistochemistry

Excised mouse lungs were inflation-fixed in 4% neutral buffered paraformaldehyde overnight at 4°C prior to paraffin embedding. Tissues were sectioned (5 µm thick) and mounted on slides. For histological analysis, sections were counterstained with hematoxylin and eosin. For immunohistochemistry (IHC), sections were incubated with rabbit polyclonal anti-cluster of differentiation (CD)68 (cat. no. BA0461; 1:200; Wuhan Boster Biological Technology, Ltd., Wuhan, China) and rat anti-mouse lymphocyte antigen 6G (cat. no. 551459; 1:200; BD Biosciences, Franklin Lakes, NJ, United States) overnight at 4°C. The following day, sections were washed three times in phosphate-buffered saline (PBS) and were incubated with biotinylated anti-rabbit or anti-rat immunoglobulin G secondary antibodies using streptavidin/peroxidase link detection kit (cat. no. SP-9001; OriGene Technologies, Inc., Beijing, China) and Polink-1 HRP detection system for rat primary antibody (cat. no. PV-6004; OriGene Technologies, Inc.); at 37°C for 30 min. Tissues were then washed three times in PBS and were incubated with horseradish peroxidase (HRP)-conjugated streptavidin for 15 min. The tissues were washed a further three times in PBS and were developed in 3,3′-diaminobenzidine (OriGene Technologies, Inc., Beijing, China) for 3–5 min until a brown color appeared. Tissues were then washed five times in water, were counterstained with hematoxylin for 15–30 sec, were washed a further five times in water, and were finally washed with serial dilutions of ethanol and xylene. Inverted microscope was used for all observations.

BALF collection and multiplex antibody array

BALF samples were collected and were analyzed, as described in a previous study (14). Briefly, BALF collection was performed using three aliquots of 1 ml 0.9% saline. The BALF fraction was then separated by centrifugation at 400 × g for 10 min at 4°C. Bronchoalveolar lavage cell numbers were counted by three people blind to the experimental condition. The cell suspension was stained with Diff-Quik stain kit (Shanghai Yuanye Biotechnology Co., Ltd., Shanghai, China) in order to assess BALF inflammatory cell types in cell smears. Multiplex antibody arrays (Quantibody® Mouse Inflammation Array 1; Raybiotech, Inc., Norcross, GA, USA) were conducted on BALF supernatant fluid according to the manufacturer's protocol, and the amount of inflammatory cytokines and chemokines were determined based on a logarithmic regression standard curve.

Western blot analysis

Proteins were extracted from lung tissue homogenates using the KeyGEN Nuclear and Cytoplasmic Protein Extraction kit (Nanjing Keygen Biotech Co., Ltd., Nanjing, China). Protein concentration was quantified using a bicinchoninic acid assay kit (Dingguo Changsheng Biotechnology Co., Ltd., Beijing, China) Equal quantity (50 µg) of nuclear protein were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (12% resolving gel and 5% stacking get) and were transferred to polyvinylidene fluoride membranes (EMD Millipore, Bedford, MA, USA). The membranes were then blocked for 1 h at 37°C in 5% non-fat milk, and were incubated with phosphorylated (p)-NF-κB (cat. no. 3033S; 1:1,000; Cell Signaling Technology, Inc., Danvers, MA, United States) primary antibodies overnight at 4°C. The primary antibody was detected using a rabbit HRP-conjugated secondary antibody (cat. no. BS13278; 1:10,000; Bioworld Technology, Inc., St. Louis Park, MN, USA). The blots were visualized using a Chemiluminescent HRP Substrate (EMD Millipore). Results were quantified using Image J version 1.4 software (National Institutes of Health, Bethesda, MD, USA) and are presented as optical density per square millimeter. Lamin B-1 was used as control antibody (cat. no. BS3547; 1:1,000, Bioword Technology, Inc.)

Statistical analysis

All experiments were conducted three times and are reproducible. Data are presented as the mean ± standard error of the mean. Statistical significance for each variable was estimated using Student's t-test, or two-way analysis of variance followed by least squares means multiple comparisons test using SAS version 9.2 (SAS Institute, Inc., Cary, NC, USA). P<0.05 was considered to indicate a statistically significant difference.

Results

Effects of urethane on body weight and lung tumor incidence in C57BL/6J mice

The body weights of the experimental mice were detected once a week, up to week 28. Body weight was reduced in the urethane-treated group compared with in the saline-treated control group during and after urethane administration (Fig. 1B). The continuous i.p injection of urethane over 10 weeks induced 100% lung tumor incidence at week 28 (no. of mice with tumors/no. of mice injected; data not shown), and tumors were particularly evident (Fig. 1C). Histopathological analysis was conducted, and the lungs of the urethane-treated group exhibited the following morphological alterations: Epithelial hyperplasia, atypical adenomatous hyperplasia (AAH) and adenoma (AD) (Fig. 1D); however, no adenocarcinomas were observed at week 28.

Effects of urethane on lung inflammation

The number of immune cells in the BALF was significantly different between the urethane-treated mice and control mice at week 13. Urethane-treated mice exhibited an overall increased number of cells in the BALF (data not shown), and the number of macrophages, polymorphonuclear cells and lymphocytes were increased to varying degrees, as determined by Diff-Quik staining (Fig. 2A). Based on these results, the present study aimed to determine whether lung tissues exhibited the same changes. The results of IHC demonstrated that macrophages and neutrophils were increased in the lung tissues of urethane-treated mice compared with in saline-treated mice at week 28 (Fig. 2B).

To determine the circulating levels of cytokines and chemokines in BALF at week 13, multiplex antibody arrays were conducted. The expression levels of cytokines and chemokines in BALF were significantly different between the two groups. Several important cytokines and chemokines involved in lung inflammation were detected (Fig. 3). BALF levels of several important proinflammatory cytokines and chemokines, including interleukin (IL)-6, regulated upon activation normal T cell expressed and secreted (RANTES), thymus and activation regulated chemokine (TARC) and TIMP metallopeptidase inhibitor 1 (TIMP-1) were significantly increased in the urethane-treated group. However, the levels of anti-inflammatory cytokines and chemokines, such as IL-2, IL-4, IL-10 and IL-13 were downregulated in BALF from the urethane-treated mice compared with the controls. Furthermore, the levels of granulocyte-colony stimulating factor (CSF), macrophage inflammatory protein (MIP)-1γ, tumor necrosis factor receptor (TNFR)I and TNFRII were significantly increased in urethane-treated mice, and the expression levels of CD30 ligand, interferon γ, IL-1α, IL-1β, IL-7, IL-15, IL-17, C-X-C motif chemokine 5, macrophage-CSF and MIP-1α were significantly decreased compared with in the control group.

Expression of the transcription factor NF-κB following urethane treatment

The expression levels of p-NF-κB were detected in lung tissues from the urethane-treated and saline-treated mice by western blotting at weeks 13 and 28 (Fig. 4). NF-κB activation was increased following urethane treatment, and the expression levels increased in a time-dependent manner.

Discussion

Genetic background has been reported to have an important role in the induction and development of lung injury in humans (5) and animals (6), and various species of mice exhibit various levels of sensitivity to induced lung cancer. Miller et al (13) reported that a single dose of urethane does not induce a high incidence of AD in B6 mice; however, 10 weekly urethane injections induced ~100% lung tumor incidence. The present study was designed to explore whether inflammation has a role in lung cancer induced by several injections of urethane in C57BL/6J mice. The results demonstrated that the continuous i.p administration of urethane over 10 weeks induced 100% lung tumor incidence, which was consistent with a previous study (13). AAH and AD were the predominant morphological changes observed in the urethane model; of which AD was shown to be similar to human lung cancer.

Inflammation has a key role in cancer. Raposo et al (15) demonstrated that inflammatory cells are able to produce reactive oxygen species and reactive nitrogen intermediates, which increase the mutation rate of cells, induce DNA damage and increase genomic instability; these molecules also inactivate mismatch repair functions, thus supporting tumor promotion. Due to the close association between inflammation and cancer (1619), the present study aimed to evaluate whether inflammatory changes appear prior to the appearance of hyperplasia or tumor. It was determined that inflammatory changes occurred at week 13; however, tumorigenesis was not observed until week 28. Redente et al (20) reported that macrophages in normal lungs were located in the alveolar interstitia and airways, whereas macrophages adjacent to tumors and neutrophil accumulation were observed in the lungs of urethane-treated A/J mice. In the present study, compared with the saline control group, urethane-treated mice exhibited increased numbers of macrophages and neutrophils (Fig. 2) in BALF and lung tissues. Among the inflammatory cell types in the lungs, macrophages are the most abundant. Depending on microenvironmental cues, these cells are able to stimulate inflammatory responses via the secretion of proinflammatory cytokines, or suppress immune responses by releasing high levels of anti-inflammatory cytokines. IL-6 is a multifunctional cytokine that may regulate immune and inflammatory responses, including control of the acute phase response at the beginning of acute inflammation, regulation of B-cell and T-cell differentiation and activation, and promotion of cell growth and survival (21). Other members of the IL family associated with lung cancer include IL-2, IL-4 and IL-10 (22). IL-2-activated NK cells are able to induce regression of established lung tumors (22). IL-4 is an anti-inflammatory cytokine, which reduces the production of proinflammatory cytokines by monocytes and with direct antiproliferative effects in some tumors (22). Additionally, it induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion and stimulates 15-hydroxyprostaglandin dehydrogenase activity mediated by janus kinase-signal transducer and activator of transcription 6, mitogen-activated protein kinase, phosphoinositide 3-kinase/Akt and protein kinase C signaling pathways (22). IL-10 is an immunosuppressive cytokine involved in carcinogenesis via immune escape (22). RANTES is a C-C chemokine that serves as a chemoattractant for various cells. Conti and DiGioacchino (23) identified RANTES as a mediator of inflammation. In the present study, the expression levels of proinflammatory cytokines and chemokines, including IL-6, RANTES, TARC and TIMP-1 were significantly increased in BALF from urethane-treated mice, whereas the levels of anti-inflammatory cytokines and chemokines, such as IL-2, IL-4, IL-10 and IL-13 were down-regulated (Fig. 3). Chronic inflammation is a characteristic phenotype of urethane-induced tumorigenesis. Narayan and Kumar (24) reported that urethane-induced lung tumorigenesis in BALB/c mice may be caused by chronic lung inflammation.

The NF-κB transcription factor functions as a crucial regulator of inflammation, the immune response, and cell survival (25,26). In addition, NF-κB has been implicated in cellular transformation and tumorigenesis, and has been revealed to be activated at the early stages of carcinogenesis (27,28). In mice treated with several injections of urethane, NF-κB was activated in the lung tissues, and its expression increased in a time-dependent manner (Fig. 4). These results were inconsistent with those of Stathopoulos et al (28); however, C57BL/6 mice received weekly i.p injections of urethane for only 4 weeks in this previous study. The results of the present study suggested that the duration of urethane injections may have an important role in the activation of NF-κB.

In conclusion, the present study determined that the accumulation of lung inflammation was associated with the occurrence of lung cancer in C57BL/6J mice., Due to the extensive application of C57BL/6J mice in lipid metabolism-associated lung cancer research, multiple injections of urethane may be potential experimental animal models.

Abbreviations:

BALF

bronchoalveolar lavage fluid

AAH

adenomatous hyperplasia

AD

adenoma

Acknowledgments

The present study was supported by grants from the Natural Science Foundation of China (NSFC, grant no. 81071907), the Natural Science Foundation of Chong Qing (CSTC, grant no. 2011BB5128) and the Program for New Century Excellent Talents in University, China (grant no. NCET-10-0997).

References

1 

Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI

2 

Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Malkinson AM: Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp Lung Res. 24:541–555. 1998. View Article : Google Scholar : PubMed/NCBI

4 

Nonas S, Miller I, Kawkitinarong K, Chatchavalvanich S, Gorshkova I, Bochkov VN, Leitinger N, Natarajan V, Garcia JG and Birukov KG: Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injury. Am J Respir Crit Care Med. 173:1130–1138. 2006. View Article : Google Scholar : PubMed/NCBI

5 

Lagan AL, Melley DD, Evans TW and Quinlan GJ: Pathogenesis of the systemic inflammatory syndrome and acute lung injury: Role of iron mobilization and decompartmentalization. Am J Physiol Lung Cell Mol Physiol. 294:L161–L174. 2008. View Article : Google Scholar

6 

Moraes TJ, Zurawska JH and Downey GP: Neutrophil granule contents in the pathogenesis of lung injury. Curr Opin Hematol. 13:21–27. 2006. View Article : Google Scholar

7 

Malkinson AM and Beer DS: Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice. J Natl Cancer Inst. 70:931–936. 1983.PubMed/NCBI

8 

Bernert H, Sekikawa K, Radcliffe RA, Iraqi F, You M and Malkinson AM: Tnfa and Il-10 deficiencies have contrasting effects on lung tumor susceptibility: Gender-dependent modulation of IL-10 haploinsufficiency. Mol Carcinog. 38:117–123. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Doris K, Karabela SP, Kairi CA, Simoes DC, Roussos C, Zakynthinos SG, Kalomenidis I, Blackwell TS and Stathopoulos GT: Allergic inflammation does not impact chemical-induced carcinogenesis in the lungs of mice. Respir Res. 11:1182010. View Article : Google Scholar : PubMed/NCBI

10 

Bartsch H and Nair J: Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: Role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg. 391:499–510. 2006. View Article : Google Scholar : PubMed/NCBI

11 

Azad N, Rojanasakul Y and Vallyathan V: Inflammation and lung cancer: Roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev. 11:1–15. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Candido J and Hagemann T: Cancer-related inflammation. J Clin Immunol. 33(Suppl 1): S79–S84. 2013. View Article : Google Scholar

13 

Miller YE, Dwyer-Nield LD, Keith RL, Le M, Franklin WA and Malkinson AM: Induction of a high incidence of lung tumors in C57BL/6 mice with multiple ethyl carbamate injections. Cancer Lett. 198:139–144. 2003. View Article : Google Scholar : PubMed/NCBI

14 

Lian X, Qin Y, Hossain SA, Yang L, White A, Xu H, Shipley JM, Li T, Senior RM, Du H and Yan C: Overexpression of Stat3C in pulmonary epithelium protects against hyperoxic lung injury. J Immunol. 174:7250–7256. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Raposo TP, Beirão BC, Pang LY, Queiroga FL and Argyle DJ: Inflammation and cancer: Till death tears them apart. Vet J. 205:161–174. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Kanterman J, Sade-Feldman M and Baniyash M: New insights into chronic inflammation-induced immunosuppression. Semin Cancer Biol. 22:307–318. 2012. View Article : Google Scholar : PubMed/NCBI

17 

Gonda TA, Tu S and Wang TC: Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle. 8:2005–2013. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Albini A and Sporn MB: The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer. 7:139–147. 2007. View Article : Google Scholar : PubMed/NCBI

19 

Porta C, Larghi P, Rimoldi M, Totaro MG, Allavena P, Mantovani A and Sica A: Cellular and molecular pathways linking inflammation and cancer. Immunobiology. 214:761–777. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Redente EF, Orlicky DJ, Bouchard RJ and Malkinson AM: Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice. Am J Pathol. 170:693–708. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Nguyen DP, Li J and Tewari AK: Inflammation and prostate cancer: The role of interleukin 6 (IL-6). BJU Int. 113:986–992. 2014. View Article : Google Scholar

22 

Cho WC, Kwan CK, Yau S, So PP, Poon PC and Au JS: The role of inflammation in the pathogenesis of lung cancer. Expert Opin Ther Targets. 15:1127–1137. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Conti P and DiGioacchino M: MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc. 22:133–137. 2001. View Article : Google Scholar : PubMed/NCBI

24 

Narayan C and Kumar A: Constitutive over expression of IL-1β, IL-6, NF-κB, and Stat3 is a potential cause of lung tumorgenesis in urethane (ethyl carbamate) induced Balb/c mice. J Carcinog. 11:92012. View Article : Google Scholar

25 

Hayden MS and Ghosh S: Signaling to NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI

26 

Baker RG, Hayden MS and Ghosh S: NF-κB, inflammation, and metabolic disease. Cell Metab. 13:11–22. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and Ben-Neriah Y: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 431:461–466. 2004. View Article : Google Scholar : PubMed/NCBI

28 

Stathopoulos GT, Sherrill TP, Cheng DS, Scoggins RM, Han W, Polosukhin VV, Connelly L, Yull FE, Fingleton B and Blackwell TS: Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Proc Natl Acad Sci USA. 104:18514–18519. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October-2016
Volume 14 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu C, Zhou L, Lu L, Chen T, Wei S, Lin X and Lian X: Inflammation has a role in urethane‑induced lung cancer in C57BL/6J mice. Mol Med Rep 14: 3323-3328, 2016
APA
Xu, C., Zhou, L., Lu, L., Chen, T., Wei, S., Lin, X., & Lian, X. (2016). Inflammation has a role in urethane‑induced lung cancer in C57BL/6J mice. Molecular Medicine Reports, 14, 3323-3328. https://doi.org/10.3892/mmr.2016.5661
MLA
Xu, C., Zhou, L., Lu, L., Chen, T., Wei, S., Lin, X., Lian, X."Inflammation has a role in urethane‑induced lung cancer in C57BL/6J mice". Molecular Medicine Reports 14.4 (2016): 3323-3328.
Chicago
Xu, C., Zhou, L., Lu, L., Chen, T., Wei, S., Lin, X., Lian, X."Inflammation has a role in urethane‑induced lung cancer in C57BL/6J mice". Molecular Medicine Reports 14, no. 4 (2016): 3323-3328. https://doi.org/10.3892/mmr.2016.5661